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HypertensionAbstract Background: Involvement of genetic factors like gene polymorphisms was found to con-
tribute significantly to development and progression of Primary Open Angle Glaucoma (POAG) in
the last few decades.
Aim of study: The present study was carried out to investigate association of PPAR-c
(rs10865710) and CYP46A1 (rs754203) gene polymorphism with development of POAG in hyper-
tensive North Indians.
Patients and methods: Study included 328 individuals, 226 as POAG cases and 102 controls.
PPAR-c and CYP46A1 gene polymorphism was evaluated by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP). The genotypic and allelic frequency distri-
bution in patients and controls was analyzed by SPSS (version 12.0).
Results: In CYP46A1 gene polymorphism, TT genotype and T allele were found to be associated
with a significantly decreased risk of POAG whereas the CT, CC genotypes and C allele were asso-
ciated with an increased risk of POAG in both hypertensive and normotensive individuals. In
PPAR-c gene polymorphism, only GG genotype was nearly associated with POAG in only
hypertensive cases.gamma;
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tensive North Indians, Egypt J Med Hum GConclusions: CYP46A1 (rs754203) gene polymorphism was associated with POAG in both
hypertensive and normotensive patients whereas, only GG genotype of PPAR-c (rs10865710)
SNP shows significant association with POAG in hypertensive POAG patients.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
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Glaucoma is a multifactorial, complex disease considered to be
the second leading cause of blindness around the globe. It is
estimated that by 2020 over 11.1 million people will be bilater-
ally blind from primary glaucoma [1]. Primary Open Angle
Glaucoma (POAG) is the most common type of glaucoma,
characterized by an elevated intraocular pressure
(IOP > 21 mmHg) which can ultimately destroy the optic
nerve cells resulting in gradual visual loss. However, high
IOP alone does not cause glaucoma apart from being a signif-
icant risk factor since patients with normal range IOP were
also found to develop glaucoma. The other risk factors pro-
posed to play a role in the development of POAG are older
age, positive family history, ethnicity, myopia, diabetes, hyper-
tension and genetic mutations [2]. Various population-based
studies covering different ethnic backgrounds have consis-
tently found an association between high blood pressure and
IOP [3–6]. A study reported that the risk of developing POAG
was 17% in hypertensive population as compared to healthy
population [7]. However, despite the clear association between
blood pressure and IOP, the exact relationship between blood
pressure and open-angle glaucoma is still unclear. Over the
past, genetic studies have substantially contributed to the
study of glaucoma. Various genetic loci including a number
of genes have also been reported to contribute to POAG sus-
ceptibility like MYOC, ASB10, WDR36, NTF4, and TBK1
genes. In this study we focused on peroxisome proliferator-
activated receptor gamma (PPAR-c) and cholesterol-24S-
hydroxylase (CYP46A1) genes with the risk of POAG in
hypertensive North Indians.
PPARs were initially identified as a peroxisome proliferator
‘‘binding-protein” capable of inducing hepatocyte peroxisome
proliferation. PPAR-c is a type II nuclear receptor which is
encoded by the PPAR-c gene in humans. Like other PPAR
subtypes, PPAR-c is constitutively expressed in the whole
retina [8], most specifically in the retinal pigment epithelia
[9]. It is involved in optic nerve damage and glaucomatous reti-
nal dysfunction. PPAR-c polymorphisms were found to be sig-
nificantly associated with diabetic retinopathy [10,11].
Activation of PPAR-c may play an important role in regulat-
ing the expression of target genes that are involved in lipid and
fatty acid metabolism in the photoreceptor renewal process
[12]. CYP46A1 is a cholesterol-metabolizing enzyme which is
expressed in the neuronal part of the retina, specifically in
the retinal ganglion cells [13,14]. It holds importance in context
to POAG since it was found that cholesterol and cholesterol
metabolism are somewhere involved in the pathogenesis of
glaucoma [15]. CYP46A1 gene had been found to be associated
with Alzheimer’s disease [16,17] and neurodegeneration. A
single-nucleotide polymorphism (SNP) in CYP46A1
(rs754203) was proposed to be a genetic risk factor for POAGal., PPAR-c and CYP46A1 genes poly
enet (2016), http://dx.doi.org/10.1016/jand a recent study showed a positive association between an
intronic SNP (rs754203) in CYP46A1 gene with POAG in a
French population [18].
The purpose of the present study was to explore the associ-
ation of PPAR-c and CYP46A1 gene polymorphism along
with the effect of hypertension on POAG risk in the North
Indian population.
2. Subjects and methods
2.1. Patient selection
After approval of the study protocol by the Institutional Ethics
Committee and obtaining patients consent, a total of 226
blood samples of POAG cases (where 108 were hypertensives
and 118 were normotensives) and 102 controls were collected
from the Department of Ophthalmology at Era’s Lucknow
Medical College & Hospital, Lucknow. Data collection was
done for each patient on clinical variables including age, alco-
hol consumption, body mass index, height, weight, cigarette
smoking and family history. Each subject underwent a com-
plete ophthalmological examination.
Patients with POAG were defined by the presence of an
open angle, pathological cupping of the optic disc, a glaucoma
hemifield test (GHT) outside normal limits with reproducible
visual field defects at the same location on two consecutive vis-
its, and an IOP >21 mmHg without anti-glaucoma drugs.
Cup-to-disc ratios were between 0.4 and 0.9. Patients with a
history of eye surgery before the diagnosis of glaucoma, evi-
dence of secondary glaucoma such as exfoliation, pigment
dispersion or uveitis and other causes were excluded.
POAG patients with a sustained diastolic blood pressure
(DBP) >90 mmHg that is accompanied by an elevated systolic
blood pressure (SBP) >140 mmHg were considered as hyper-
tensives (according to the WHO diagnostic criteria of hyper-
tension). These patients had a prior history of hypertension
before the commencement of POAG. We also included age,
sex and ethnicity matched control group who were non smok-
ers and had neither hypertension nor any other systemic ill-
ness. They had no family or personal history of glaucoma.
Our work was carried out in accordance with the Code of
Ethics of the World Medical Association (Declaration of
Helsinki).2.2. DNA extraction
Five milliliters of peripheral blood was collected from all the
subjects in 0.5 M EDTA tubes. Genomic DNA was isolated
from whole blood using the standard phenol–chloroform
extraction method [19]. The DNA concentration was deter-
mined by spectrophotometer and stored at 20 C.morphism is associated with Primary Open Angle Glaucoma (POAG) in hyper-
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2.3.1. PPAR-c polymorphism
Genotyping was performed using PCR-RFLP with the follow-
ing primer: The forward primer 50-CAA GCC CAG TCC TTT
CTG TG-30 and the reverse primer 50-AGT GAA GGA ATC
GCT TTC CG-30 [20]. All reactions were performed in a total
volume of 50 ll containing 10 mmol/L Tris HCl (pH 8.8),
50 mmol/L KCl, 1.5 mmol/L MgCl2, 0.2 mmol of each dNTP,
50 pmol of each primer, 1 U Taq DNA polymerase and 200 lg
of genomic DNA. PCR was performed using an MJ mini per-
sonal thermal cycler (Bio-Rad). The amplification program
included: Initial precycling denaturation by holding at 94 C
for 3 min, denaturation for 40 cycles at 94 C for 30 s followed
by annealing at 53 C for 30 s, extension at 72 C for 1 min and
a final extension period at 72 C for 9 min. Restriction frag-
ment length polymorphism (RFLP) will be detected after
digestion over night with 2 U of the restriction enzyme Hpa
II (New England Biolabs Inc., USA) which cuts the mutant
allele at a site introduced by the reverse primer. Samples were
applied to 3% agarose gel and subjected to electrophoresis for
about half an hour and visualized on a UV transilluminator
after ethidium bromide staining. PPAR-c homozygous for
CC genotype corresponded to the 106-bp fragment, whereas
the heterozygous CG was characterized by two fragments of
106 and 130 bp (Fig. 1).
2.3.2. CYP46A1 polymorphism
Genotyping was performed using PCR-RFLP with the follow-
ing primer: forward primer: 50-TGAAAACGAGTTTCCC-
GTCC-30; reverse primer: 50-GTGTGACCAGGTAA
CAGTCA-30 [18] in a 12.5-ll volume reaction with 1.25 U of
Taq DNA polymerase, 1.5 mM of MgCl2, 1.25 ll of 10XFigure 1 3% agarose gel picture showing PCR-RFLP product of PPA
and L7 show CG(+/) genotype (130 and 106 bp band), lane L8 show
Please cite this article in press as: Raza ST et al., PPAR-c and CYP46A1 genes poly
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an MJ mini personal thermal cycler (Bio-Rad). The amplifica-
tion program included: initial denaturation at 95 C for 8 min,
after which the reaction mixture was subjected to 50 cycles of
1-min denaturation at 95 C, 1-min annealing at 53 C, and a
2-min extension at 72 C, followed by a final extension at
72 C for 5 min. The PCR products were digested by MspI
(New England Biolabs Inc., USA) over night. The fragment
amplification and digestion results were revealed by 1.8%
agarose gel electrophoresis and visualized on a UV transillumi-
nator after ethidium bromide staining. The CYP46A1*T allele
corresponded to the uncut 285-bp fragment, whereas the
CYP46A1*C allele was characterized by two fragments of
209 and 76 bp (Fig. 2).
We validated 25% of our genotyping results through Direct
sequencing technique.
2.4. Statistical analysis
Clinical data are expressed as mean ± SD. The genotyping
data were compared between cases and controls using
Chi-square test. p-values 6 0.05 were considered as significant.
Odds ratios (OR) and 95% confidence intervals (CI) were cal-
culated to test the relative risk for association. Other variables
will be compared using Student’s t-test for normally-
distributed variables. All statistical tests were performed using
SPSS (Statistical Package for the Social Sciences) version 12
software.
3. Results
Our study included 328 individuals, 226 as POAG cases (108
with and 118 without hypertension) and 102 age, sex andR-c gene, lane L1 shows undigested product. Lanes L2, L3, L4, L6
s GG (/) genotype (130 bp) and lane L5 shows 100 bp ladder.
morphism is associated with Primary Open Angle Glaucoma (POAG) in hyper-
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Figure 2 1.8% agarose gel picture showing PCR product for CYP46A1 gene polymorphism. Lane L7 shows C/T genotype (285, 209,
76 bp), lanes L3 and L4 show C/C genotype (209, 76 bp), lanes L2, L6, and L8 show T/T genotype (285 bp) and lane L5 shows 100 bp
ladder.
Table 1 Biochemical and clinical characteristics of study subjects.
Parameters POAG with hypertension
cases (N= 108)
Normotensive POAG
cases (N= 118)
Controls (N= 102)
Gender (M/F) 61/47 56/62 52/50
Age (yrs) 45.02 ± 17.65 47.03 ± 12.88 40.41 ± 11.29
SBP (mm Hg) 144.96 ± 15.82 100 ± 11.54 112.23 ± 9.07
DBP (mm Hg) 90.12 ± 8.57 75 ± 9.7 74.85 ± 10.01
S. Cholesterol (mg/dl) 181.11 ± 56.88 166.73 ± 24.17 170.52 ± 18.27
TG (mg/dl) 178.06 ± 110.55 137.35 ± 44.16 140 ± 36.72
HDL (mg/dl) 45.767 ± 8.7929 55.23 ± 9.59 50.252 ± 8.53
VLDL (mg/dl) 33.53 ± 16.7 30.83 ± 11.64 30.41 ± 18.54
LDL (mg/dl) 103.78 ± 31.926 89.60 ± 18.53 91.82 ± 43.45
Values are means ± S.D.
N, number of subjects; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, Triglycerides; HDL, High Density Lipoproteins;
VLDL, Very Low Density Lipoproteins; LDL, Low Density Lipoproteins.
4 S.T. Raza et al.ethnicity matched controls. Clinical and biochemical parame-
ters of cases and controls are shown in Table 1.
3.1. Hardy–Weinberg equilibrium test
PPAR-c and CYP46A1 genotype distributions in all cases and
controls were in line with Hardy–Weinberg equilibrium (all
p> 0.05, data not shown).
3.2. Power of study
Powers were calculated for various values of the Bonferroni
corrected p values (alpha) for the specified sample size and pro-
portions using the formula given by Indrayan [21]. Then an
average value of such powers is taken. Genetic power estima-Please cite this article in press as: Raza ST et al., PPAR-c and CYP46A1 genes poly
tensive North Indians, Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/jtion showed that cases and controls had >80% power to
detect association between PPAR-c and CYP46A1 gene poly-
morphism and POAG in the hypertensive and normotensive
North Indian population.
3.3. Genetic polymorphism analysis
3.3.1. PPAR-c polymorphism analysis
Compared to the healthy control group (40%), the frequency
of GG genotype was significantly lower in hypertensive POAG
patients (26.85%; p= 0.04) but it was not significant in pure
POAG patients (27.97%; p= 0.056). No significant associa-
tion was found between frequencies of C and G alleles in
hypertensive (48.15%, p= 0.101 and 51.85%, p= 0.101
respectively) and normotensive POAG cases (47.03%,morphism is associated with Primary Open Angle Glaucoma (POAG) in hyper-
.ejmhg.2016.04.005
Table 2 Genotypes and alleles frequencies of PPAR-c gene in cases and controls.
GENOTYPE/ALLELE Controls (102) Normotensive POAG cases (118) OR 95% CI c2 p values Bonferroni
corrected p values
N Frequency (%) N Frequency (%)
CG 40 39 59 50 1.55 0.91–2.65 2.57 0.109 0.327
CC 21 21 26 22.03 1.09 0.57–2.08 0.07 0.794 1
GG 41 40 33 27.97 0.58 0.33–1.01 3.67 0.056 0.167
C 82 40.2 111 47.03 1.32 0.90–1.93 2.08 0.149 0.299
G 122 59.8 125 52.97 0.76 0.51–1.13 1.85 0.149 0.299
Average power of study: 0.842
GENOTYPE/ALLELE Controls (102) POAG cases with
hypertension (108)
OR 95% CI c2 p values Bonferroni
corrected p values
N Frequency (%) N Frequency (%)
CG 40 39 54 50 1.55 0.90–2.68 2.47 0.116 0.349
CC 21 21 25 23.15 1.16 0.60–2.24 0.20 0.654 1
GG 41 40 29 26.85 0.55 0.31–0.98 4.20 0.04 0.121
C 82 40.2 104 48.15 1.38 0.94–2.03 2.69 0.101 0.202
G 122 59.8 112 51.85 0.72 0.49–1.07 2.69 0.101 0.202
Average power of study: 0.864
GENOTYPE/ALLELE POAG cases with
hypertension (108)
Normotensive
POAG cases (118)
OR 95% CI c2 p values Bonferroni
corrected p values
N Frequency (%) N Frequency (%)
CT 54 50 59 50 1 0.59–1.69 0.00 1 1.000
TT 25 23.15 26 22.03 1.07 0.57–1.99 0.04 0.841 1.000
CC 29 26.85 33 27.97 0.95 0.53–1.70 0.04 0.851 1.000
C 112 51.85 125 52.97 0.96 0.66–1.38 0.06 0.813 1.000
T 104 48.15 111 47.03 1.05 0.72–1.51 0.06 0.813 1.000
Average power of study: 0.625
PPAR-c and CYP46A1 gene polymorphism in POAG 5p= 0.149 and 52.97%, p= 0.149 respectively) as compared to
controls (40.2% and 59.8% respectively). No significant differ-
ences were observed in genotype and allele frequencies on com-
paring hypertensive POAG study group with pure POAG
study group as shown in Table 2.
3.3.2. CYP46A1 polymorphism analysis
The frequencies of CT; CC genotypes and C allele were signif-
icantly higher in both hypertensive POAG (51.85%,
p= 0.002; 19.44%, p= 0.002 and 45.37%, p< 0.001) and
pure POAG cases (49.15%, p= 0.002; 18.65%, p< 0.001
and 43.22%, p< 0.001) as compared to controls (28.43%,
p= 0.002; 3.92%, p< 0.001 and 18.14%, p< 0.001) respec-
tively. In contrast, the frequencies of TT genotype and T allele
were significantly lower in both hypertensive POAG (28.70%,
p< 0.001 and 54.63%, p< 0.001) and normotensive POAG
cases (32.2%, p< 0.001 and 56.78%, p< 0.001) as compared
to controls (67.65%, p< 0.001 and 81.86%, p< 0.001),
respectively. No significant differences were observed in geno-
type and allele frequencies on comparing hypertensive POAG
study group with pure POAG study group as shown in
Table 3.4. Discussion
POAG is a heterogeneous disease where genetic factors and
environmental factors interact in predisposing an individual
to disease risk. The etiology of POAG is still not well under-Please cite this article in press as: Raza ST et al., PPAR-c and CYP46A1 genes poly
tensive North Indians, Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/j.stood and the present studies in this field aimed to develop
techniques for early identification of patients before the onset
of clinical phenotype manifestation. A number of genes have
been found to be associated with POAG but the studies failed
to detect a substantial biomarker gene which confers signifi-
cantly high-risk of developing glaucoma in future. This is the
first association study between PPAR-c and CYP46A1 gene
polymorphism and the risk of POAG in the North Indian
hypertensive population.
Activation of PPAR-c gene might be involved in neurode-
generation that occurs during diabetic retinopathy. The anti-
inflammatory effect of PPAR-c helps in preventing the possible
deleterious effect of fatty acid accumulation in the retina lead-
ing to neuroprotection. In this context, a significant associa-
tion was found between PPAR-c gene (Gly482Ser)
polymorphism and diabetic retinopathy disease mechanism
in Caucasians [11]. The PPAR-c gene (rs1797912) allele fre-
quencies were found to be almost same in POAG cases and
controls in a Chinese population (p= 0.16) but differed in
Asian report [22]. In our study, it was observed that GG geno-
type frequency of PPAR-c gene polymorphism (rs10865710)
was higher in controls (40%) as compared to normotensive
POAG cases (27.97%, p= 0.056) and was further lowered in
hypertensive POAG cases (26.85%, p= 0.04). Similarly, the
frequency of C allele was higher in POAG cases both with
and without hypertension as compared to controls but the dif-
ference was statistically insignificant. On the other hand the
frequencies of G allele were found to be higher in control
group than both the studied POAG cases but this differencemorphism is associated with Primary Open Angle Glaucoma (POAG) in hyper-
ejmhg.2016.04.005
Table 3 Genotypes and alleles frequencies of CYP46A1 gene in cases and controls.
GENOTYPE/ALLELE Controls (102) Normotensive POAG cases (118) OR 95% CI c2 p values Bonferroni
corrected p values
N Frequency (%) N Frequency (%)
CT 29 28.43 58 49.15 2.43 1.39–4.27 9.83 0.002 0.005
TT 69 67.65 38 32.2 0.23 2.50–7.76 27.51 <0.001 <0.001
CC 4 3.92 22 18.65 5.61 1.87–16.90 11.38 <0.001 0.002
C 37 18.14 102 43.22 3.44 2.21–5.33 31.85 <0.001 <0.001
T 167 81.86 134 56.78 0.29 0.19–0.45 31.85 <0.001 <0.001
Average power of study: 0.986
GENOTYPE/ALLELE Controls (102) POAG cases with
hypertension (108)
OR 95% CI c2 p values Bonferroni
corrected p values
N Frequency (%) N Frequency (%)
CT 29 28.43 56 51.85 2.71 1.53–4.80 11.94 <0.001 0.002
TT 69 67.65 31 28.70 0.19 0.11–0.35 31.89 <0.001 <0.001
CC 4 3.92 21 19.44 5.91 1.95–17.90 12.05 <0.001 0.002
C 37 18.14 98 45.37 3.75 2.40–5.85 35.67 <0.001 <0.001
T 167 81.86 118 54.63 0.27 0.17–0.42 35.67 <0.001 <0.001
Average power of study: 0.988
GENOTYPE/ALLELE POAG cases with
hypertension (108)
Normotensive
POAG cases (118)
OR 95% CI c2 p values Bonferroni
corrected p values
N Frequency N Frequency
CT 56 51.85 58 49.15 1.11 0.66–1.88 0.16 0.685 1.000
TT 31 28.70 38 32.2 0.85 0.48–1.50 0.33 0.568 1.000
CC 21 19.44 22 18.65 1.05 0.54–2.05 0.02 0.878 1.000
C 98 45.37 102 43.22 1.09 0.75–1.58 0.21 0.646 1.000
T 118 54.63 134 56.78 0.92 0.63–1.33 0.21 0.646 1.000
Average power of study: 0.714
6 S.T. Raza et al.was also not found to be significant (p> 0.001). It could be
thus inferred that the GG genotype was significantly associ-
ated with a negative risk for POAG in hypertensive POAG
cases.
CYP46A1 gene encodes for the enzyme involved in
cholesterol-metabolism and it has been demonstrated that
cholesterol metabolism is involved in the progression of
POAG. CYP46A1 gene polymorphism was shown to be
associated with the risk of POAG in French [18] but not in
Caucasian and Chinese populations [23,24]. In our study, the
frequency of CT genotype in normotensive POAG cases
(49.15%) was similar to its frequency in French moderate
POAG cases (42.9%) and Chinese POAG cases (48.8%)
respectively [18,23], but this frequency increased to 51.85%
in the presence of hypertension in our study. Similarly, the fre-
quency of minor C allele in our study was found to be higher in
our normotensive and hypertensive POAG cases (43.22% and
45.37% respectively) as compared to its frequency in Chinese
POAG cases (30.4%) [24]. In our study, the frequency of
minor C allele was found to be significantly higher in POAG
cases with hypertension (45.37%, p< 0.001) and normoten-
sive POAG patients (43.22%, p< 0.001) as compared to con-
trol group (18.14%) where as on the other hand, the frequency
of major T allele was nearly same in both the cases of POAG
with (54.63%, p< 0.001) and without (56.78%, p< 0.001)
hypertension but was significantly lower as compared to the
control group (81.86%). This result was contradictory to
the observation in French population where, T allele in thePlease cite this article in press as: Raza ST et al., PPAR-c and CYP46A1 genes poly
tensive North Indians, Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/jCYP46A1 rs754203 SNP was associated with a higher risk
for primary open-angle glaucoma [18]. The frequency of TT
genotype in our study was found to be much lower as com-
pared to the French population (61.3%) in both normotensive
(32.2%) and hypertensive (28.7%) POAG cases [18]. The
results of this study thus show association of CYP46A1 gene
polymorphism (rs754203) with POAG where CT, CC geno-
types and C allele increase the risk of POAG while the TT
genotype and T allele show a negative association with POAG.
5. Conclusion
In summary, in the North Indian population CYP46A1
(rs754203) gene polymorphism confers the risk susceptibility
to the development of POAG both in normotensive and hyper-
tensive populations. In context to PPAR-c (rs10865710) gene
polymorphism only the GG genotype was found to be nearly
significant with POAG risk in the Hypertensive North Indian
population. Further association studies and screening of other
candidate gene polymorphisms are required to elucidate the
precise genetic susceptibility of POAG and understanding the
associated polymorphism is expected to increase the under-
standing of the course of disease.Conflict of interest
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